Despite the outstanding clinical results of immune checkpoint blockade (ICB) in melanoma and other cancers, clinical trials in breast cancer have reported low responses to these therapies. Current efforts are now focused on improving the treatment efficacy of ICB in breast cancer using new combination designs such as molecularly targeted agents, including histone deacetylase inhibitors (HDACi). These epigenetic drugs have been widely described as potent cytotoxic agents for cancer cells. In this work, we report new noncanonical regulatory properties of ultra-selective HDAC6i over the expression and function of epithelial–mesenchymal transition pathways and the invasiveness potential of breast cancer. These unexplored roles position HDAC6i as attractive options to potentiate ongoing immunotherapeutic approaches. These new functional activities of HDAC6i involved regulation of the E-cadherin/STAT3 axis. Pretreatment of tumors with HDAC6i induced critical changes in the tumor microenvironment, resulting in improved effectiveness of ICB and preventing dissemination of cancer cells to secondary niches. Our results demonstrate for the first time that HDAC6i can both improve ICB antitumor immune responses and diminish the invasiveness of breast cancer with minimal cytotoxic effects, thus departing from the cytotoxicity-centric paradigm previously assigned to HDACi.Significance: Ultraselective HDAC6 inhibitors can reduce tumor growth and invasiveness of breast cancer by noncanonical mechanisms unrelated to the previously cytotoxic properties attributed to HDAC inhibitors.
1 June 2019 in International Journal of Pharmaceutics
Knowledge of the biomechanical properties of the various interconnected ocular components is critical for understanding the physiology of the eye globe, detecting ocular diseases, and designing effective treatments and surgical procedures. For example, measuring the biomechanical properties of the cornea and sclera can help detect the early signs of glaucoma, a condition that can be characterized by increased intraocular pressure (IOP).1 By understanding how different ocular components work together to resist changes in IOP, clinicians can assess glaucoma risk and develop effective treatment strategies for managing glaucoma. Furthermore, biomechanical models of the eye can be used to design personalized therapeutic procedures for implanting intraocular lenses or performing corneal transplant surgeries, ensuring that the procedures are safe and effective.
Radiotherapy is a curative cancer treatment modality that imparts damage to cellular DNA, induces immunogenic cell death, and activates antitumor immunity. Despite the radiotherapy-induced direct antitumor effect seen within the treated volume, accumulating evidence indicates activation of innate antitumor immunity. Acute proinflammatory responses mediated by anticancer M1 macrophages are observed in the immediate aftermath following radiotherapy. However, after a few days, these M1 macrophages are converted to anti-inflammatory and pro-cancer M2 phenotype, leading to cancer resistance and underlying potential tumor relapse. Histone deacetylase 6 (HDAC6) plays a crucial role in regulating macrophage polarization and innate immune responses. Here, we report targeting HDAC6 function with a novel selective inhibitor (SP-2-225) as a potential therapeutic candidate for combination therapy with radiotherapy. This resulted in decreased tumor growth and enhanced M1/M2 ratio of infiltrating macrophages within tumors. These observations support the use of selective HDAC6 inhibitors to improve antitumor immune responses and prevent tumor relapse after radiotherapy.
Many morphogenesis processes during embryo development are fundamentally biomechanical processes, and disruption of these events can lead to debilitating congenital abnormalities. Imaging the biomechanical properties of embryos could provide insight into developmental disorders and could open new therapy avenues. However, current methods are invasive and are incapable of producing viscoelasticity maps of live samples in 3D. To overcome these limitations, we propose the use of reverberant shear wave fields in combination with optical coherence tomography (OCT) for high-resolution elastography at different developmental stages of murine embryos. A 1 kHz quasi-harmonic stimulation was applied to induce the diffuse shear field, which leveraged the heterogeneous microstructure and boundaries of the different tissue segments in the embryos. With this approach, we show how the shear wave speed (i.e., stiffness) of the spine, heart, and mid-brain increased as the embryo developed from embryonic day (E) 9.5 to E 11.5 at five separate stages. This noncontact technique is a promising method for imaging the biomechanical properties of different embryo structures during development with important applications for understanding developmental diseases and exploring treatments.
Homodimeric KATII is an enzyme involved in l-kynurenine transamination to kynurenic acid. The increase in kynurenic acid concentration is predominant in schizophrenia and other disorders. Currently, the search for new KATII inhibitors continues to be a challenge. The aim of this work was to analyze the possible role of nicotine in KATII inhibition and compare it with the reversible inhibitor NS1502. We have used computational methods of quantum mechanics, docking, molecular dynamics, and binding energy (molecular mechanics/Poisson–Boltzmann surface area). The results of chemical reactivity showed that the nucleophilic and electrophilic attacks would be more significant in nicotine than in NS1502. The molecular dynamics simulations provided a molecular understanding of the binding interaction of nicotine and NS1502 with KATII. The nicotine binding energy was similar to that of the NS1502 compound; both were placed in the same pocket. Furthermore, the energy distribution analysis of ligands to cofactor lysine pyridoxal-5′-phosphate presented similar values in both cases; consequently, the electrostatic potential of the active site was positive, which leads us to believe that nicotine behaves as the reversible inhibitor NS1502 and could play a neuroprotective role in schizophrenia.